Gil Alterovitz, from Harvard Medical School, opened the keynote for health informatics track on Tuesday (March 25, 2014). He spread the the light on one of the big hole in health informatics and research domain around data- “Appifying analytics”. He explained bunch of amazing use cases on how the health industry could… Read more about 03.28.2014 AnalyticsWeek Unconference March 2014
Contribution to new book: Pathobiology of Cancer Regimen-Related Toxicities
Chapter Abstract: “The efficacy of chemotherapy depends on several different patient factors, including age, gender, ethnicity, and genetics. A patient’s genetic composition strongly influences how chemotherapeutic agents are absorbed, distributed, metabolized, and excreted by the body. Consequently, variations in genes that are responsible for these activities play a significant role in determining the prognostic outcome for patients. Studying and identifying these associated genes have been main foci of… Read more about 10.16.2013 Chapter in new book
This week, researchers at Harvard Medical School's Biomedical Cybernetics Laboratory released two free iPad applications, available on iTunes, intended to help clinicians assess diabetes risk and improve treatment compliance in patients with the disease.
Gil Alterovitz, an assistant professor at Harvard Medical School and the HMS Center for Biomedical Informatics, told BioInform that he and colleagues developed the apps to provide a standardized method of communicating clinical and genetic information to physicians, caregivers, and patients ...